Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials

Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

Mark G. Kris, Bruce E. Johnson, Lynne D. Berry et al. · JAMA · 2014 · 1.7K citations

Medicine, Genetics, Oncology +17

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès et al. · The Lancet Oncology · 2015 · 1.1K citations

Medicine, Oncology, Molecular Oncology +14

Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to Enrollment

Primo N. Lara, Roger Higdon, Nelson Lim et al. · Journal of Clinical Oncology · 2001 · 603 citations

Medicine, Oncology, Cancer Control +13

Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials

Funda Meric‐Bernstam, Lauren Brusco, Kenna Shaw et al. · Journal of Clinical Oncology · 2015 · 430 citations · Full text

Medicine, Genetics, Oncology +17

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)

Fabrice André, Thomas Bachelot, Frédéric Commo et al. · The Lancet Oncology · 2014 · 405 citations

Medicine, Genetics, Oncology +16